Oncology
Cancer remains one of our greatest and growing healthcare challenges.1 Globally, it is estimated that 18.1 million new cancer cases occurred in 2020, with 9.6 million deaths and by 2040, the global burden is expected to grow to 28 million new cancer cases as a result of a growing and ageing population.2
But cancer isn’t a single disease. There are now more than 100 types of cancer and its biology is constantly changing, making it one of the most complex diseases to treat.3
Pfizer is developing treatments that are as diverse as the disease itself. Whilst traditional cancer-fighting tools like chemotherapy and radiation remain important treatment options for patients and doctors, our scientists are working to uncover new approaches to attack cancer cells directly and more effectively. With a focus on the most disruptive advances in science and guided by the urgency to help patients receive the next wave of life-changing cancer medicines, we hope to develop ever more targeted and sophisticated treatments that have the real potential to transform patients’ lives. We are committed to changing the trajectory of cancer.
Pfizer is proud of our long-standing support of the Science Museum Group.
Read about five advancements in healthcare which have impacted cancer over the past five years.
We created a cancer heatmap to highlight geographic focus areas where we can help improve cancer care and tackle inequalities.
References